JP2000515132A - 安定な非中毒性処方物中の非経口パクリタキセル - Google Patents
安定な非中毒性処方物中の非経口パクリタキセルInfo
- Publication number
- JP2000515132A JP2000515132A JP10504432A JP50443298A JP2000515132A JP 2000515132 A JP2000515132 A JP 2000515132A JP 10504432 A JP10504432 A JP 10504432A JP 50443298 A JP50443298 A JP 50443298A JP 2000515132 A JP2000515132 A JP 2000515132A
- Authority
- JP
- Japan
- Prior art keywords
- paclitaxel
- dma
- peg
- pharmaceutical composition
- formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.タキサンアナログ、ジメチルアセトアミド(DMA)、ポリエチレングリコー ル(PEG)、および水性脂質乳濁液を含む、非経口投与のための薬学的組成物。 2.前記タキサンアナログがパクリタキセルである、請求項1に記載の薬学的組 成物。 3.前記タキサンアナログが約1mg/ml〜約5mg/mlの濃度である、請求項1に記 載の薬学的組成物。 4.前記水性脂質乳濁液が大豆油乳濁液である、請求項1に記載の薬学的組成物 。 5.前記PEGが約400の分子量を有する、請求項1に記載の薬学的組成物。 6.DMAおよびPEGを約1:3(v/v)の比で含むとさらに規定される、請求項1に記 載の薬学的組成物。 7.脈管内投与のためのパクリタキセル組成物を調製する方法であって、以下の 工程: パクリタキセルをDMA中に約100mg/mlまでの濃度で溶解する工程; パクリタキセル溶液にポリエチレングリコール(PEG)をDMA:PEGの比で約1:3 (v/v)で添加して、約25mg/mlパクリタキセルまでの濃度を有するパクリタキセ ルストック処方物を達成する工程;および 水性脂質乳濁液を添加して、約1mg/ml〜約5mg/mlのパクリタキセル濃度を達 成する工程、 を包含する、方法。 8.請求項7に記載の方法により調製される薬学的組成物。 9.パクリタキセル感受性腫瘍を処置する方法であって、以下の工程: 約1.3(v/v)のDMA:PEG比でジメチルアセトアミド(DMA)およびポリエチレ ングリコール(PEG)を溶解し、そして約1mg/ml〜5mg/mlの最終パクリタキセ ル濃度を達成するように最終的に水性脂質乳濁液中に溶解されたパクリタキセル 含有薬学的組成物を得る工程;および 該腫瘍を該薬学的組成物と接触させる工程、 を包含する、方法。 10.前記腫瘍が被験体の中にあり、そして前記薬学的組成物が非経口的に投与 される、請求項9に記載の方法。 11.前記被験体が、ヒトの卵巣ガン患者、乳ガン患者、悪性リンパ腫患者、肺 ガン患者、またはカポージ肉腫患者である、請求項10に記載の方法。 12.前記薬学的組成物が、約135mg/m2体表面〜約250mg/m2体表面の投薬量でに 投与される、請求項9に記載の方法。 13.約25mg/mlパクリタキセルおよび1:3のv/v比のジメチルアセトアミド:ポ リエチレングリコールを含む、パクリタキセルストック処方物。 14.前記ポリエチレングリコールが、約400の分子量を有する、請求項13に 記載のパクリタキセルストック処方物。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/672,594 | 1996-06-28 | ||
US08/672,594 US5877205A (en) | 1996-06-28 | 1996-06-28 | Parenteral paclitaxel in a stable non-toxic formulation |
PCT/US1997/011503 WO1998000128A1 (en) | 1996-06-28 | 1997-06-26 | Parenteral paclitaxel in a stable non-toxic formulation |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2000515132A true JP2000515132A (ja) | 2000-11-14 |
JP2000515132A5 JP2000515132A5 (ja) | 2005-03-10 |
Family
ID=24699210
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP10504432A Ceased JP2000515132A (ja) | 1996-06-28 | 1997-06-26 | 安定な非中毒性処方物中の非経口パクリタキセル |
Country Status (9)
Country | Link |
---|---|
US (2) | US5877205A (ja) |
EP (1) | EP0920311A4 (ja) |
JP (1) | JP2000515132A (ja) |
CN (1) | CN1165300C (ja) |
AU (1) | AU722617B2 (ja) |
CA (1) | CA2259297C (ja) |
NO (1) | NO986165L (ja) |
NZ (1) | NZ333737A (ja) |
WO (1) | WO1998000128A1 (ja) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007111211A1 (ja) * | 2006-03-28 | 2007-10-04 | Nippon Kayaku Kabushiki Kaisha | タキサン類の高分子結合体 |
US8188222B2 (en) | 2006-11-08 | 2012-05-29 | Nippon Kayaku Kabushiki Kaisha | High molecular weight derivative of nucleic acid antimetabolite |
US8334364B2 (en) | 2006-11-06 | 2012-12-18 | Nipon Kayaku Kabushiki Kaisha | High-molecular weight derivative of nucleic acid antimetabolite |
US8703878B2 (en) | 2007-09-28 | 2014-04-22 | Nippon Kayaku Kabushiki Kaisha | High-molecular weight conjugate of steroids |
US8808749B2 (en) | 2009-05-15 | 2014-08-19 | Nippon Kayaku Kabushiki Kaisha | Polymer conjugate of bioactive substance having hydroxy group |
US8920788B2 (en) | 2008-03-18 | 2014-12-30 | Nippon Kayaku Kabushiki Kaisha | High-molecular weight conjugate of physiologically active substances |
US8940332B2 (en) | 2006-05-18 | 2015-01-27 | Nippon Kayaku Kabushiki Kaisha | High-molecular weight conjugate of podophyllotoxins |
US9018323B2 (en) | 2010-11-17 | 2015-04-28 | Nippon Kayaku Kabushiki Kaisha | Polymer derivative of cytidine metabolic antagonist |
US9149540B2 (en) | 2008-05-08 | 2015-10-06 | Nippon Kayaku Kabushiki Kaisha | Polymer conjugate of folic acid or folic acid derivative |
US9346923B2 (en) | 2011-09-11 | 2016-05-24 | Nippon Kayaku Kabushiki Kaisha | Method for manufacturing block copolymer |
US9434822B2 (en) | 2004-09-22 | 2016-09-06 | Nippon Kayaku Kabushiki Kaisha | Block copolymer, micelle preparation, and anticancer agent containing the same as active ingredient |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6245805B1 (en) * | 1995-10-26 | 2001-06-12 | Baker Norton Pharmaceuticals, Inc. | Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents |
US6964946B1 (en) | 1995-10-26 | 2005-11-15 | Baker Norton Pharmaceuticals, Inc. | Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same |
US20030157187A1 (en) * | 1996-12-02 | 2003-08-21 | Angiotech Pharmaceuticals, Inc. | Compositions and methods for treating or preventing inflammatory diseases |
US20030087954A1 (en) * | 1997-01-07 | 2003-05-08 | Sonus Pharmaceuticals, Inc. | Method of treating bladder carcinoma using a Taxane/Tocopherol formulation |
US6458373B1 (en) | 1997-01-07 | 2002-10-01 | Sonus Pharmaceuticals, Inc. | Emulsion vehicle for poorly soluble drugs |
US6727280B2 (en) * | 1997-01-07 | 2004-04-27 | Sonus Pharmaceuticals, Inc. | Method for treating colorectal carcinoma using a taxane/tocopherol formulation |
US20030105156A1 (en) * | 1997-01-07 | 2003-06-05 | Nagesh Palepu | Method for administration of a taxane/tocopherol formulation to enhance taxane therapeutic utility |
US6844004B2 (en) | 1997-08-15 | 2005-01-18 | Board Of Regents, The University Of Texas System | Topical formulations of natamycin/pimaricin |
US6045815A (en) * | 1997-08-15 | 2000-04-04 | Board Of Regents, The University Of Texas System | Parenteral pimaricin as treatment of systemic infections |
CN100396276C (zh) * | 1998-02-05 | 2008-06-25 | 诺瓦提斯公司 | 依普西龙组合物 |
IL131217A0 (en) * | 1998-03-10 | 2001-01-28 | Napro Biotherapeutics Inc | Novel methods and compositions for delivery of taxanes |
KR19990075621A (ko) * | 1998-03-23 | 1999-10-15 | 임성주 | 경사 평판형 배양조 |
KR100446959B1 (ko) * | 1998-04-02 | 2004-11-03 | 김종국 | 파클리탁셀주사제조성물 |
US7030155B2 (en) * | 1998-06-05 | 2006-04-18 | Sonus Pharmaceuticals, Inc. | Emulsion vehicle for poorly soluble drugs |
US6017948A (en) * | 1998-10-30 | 2000-01-25 | Supergen, Inc. | Water-miscible pharmaceutical compositions |
DE69924004T2 (de) * | 1998-12-22 | 2006-02-09 | United States Of America Represented By The Secretary, Department Of Health & Human Services | Verabreichungssystem für wasserunlösliche arzneistoffe |
US6040330A (en) | 1999-01-08 | 2000-03-21 | Bionumerik Pharmaceuticals, Inc. | Pharmaceutical formulations of taxanes |
US6121257A (en) * | 1999-03-31 | 2000-09-19 | Abbott Laboratories | Sulfamate containing macrocyclic immunomodulators |
EP2289549A3 (en) | 1999-10-01 | 2011-06-15 | Immunogen, Inc. | Immunoconjugates for treating cancer |
SE9903831D0 (sv) | 1999-10-22 | 1999-10-22 | Astra Ab | Formulation of substituted benzimidazoles |
US20040009229A1 (en) * | 2000-01-05 | 2004-01-15 | Unger Evan Charles | Stabilized nanoparticle formulations of camptotheca derivatives |
JP2003521545A (ja) | 2000-02-02 | 2003-07-15 | フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド | 改良された溶解性を有するタキサン製剤 |
EP1280557B1 (en) | 2000-05-12 | 2012-06-20 | Samyang Corporation | Method for the preparation of polymeric micelle via phase separation of block copolymer |
US7217770B2 (en) * | 2000-05-17 | 2007-05-15 | Samyang Corporation | Stable polymeric micelle-type drug composition and method for the preparation thereof |
WO2002009695A1 (en) * | 2000-08-02 | 2002-02-07 | Atossa Healthcare, Inc. | Bimodal emulsions of taxanes and butyrate polyalcohol esters |
WO2002043765A2 (en) * | 2000-11-28 | 2002-06-06 | Transform Pharmaceuticals, Inc. | Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof |
CN1555253A (zh) * | 2001-09-13 | 2004-12-15 | ������ѧ�����о�Ժ | 化疗栓塞用紫杉醇的油性组合物、制剂及它们的制造方法 |
AU2002357012A1 (en) * | 2001-11-27 | 2003-06-10 | Transform Pharmaceuticals, Inc. | Oral pharmaceutical formulations comprising paclitaxel, derivatives and methods of administration thereof |
HUP0600533A2 (en) * | 2001-11-30 | 2006-11-28 | Bristol Myers Squibb Co | Paclitaxel solvates |
US20060078618A1 (en) * | 2001-12-11 | 2006-04-13 | Constantinides Panayiotis P | Lipid particles and suspensions and uses thereof |
US20040213837A1 (en) * | 2002-08-05 | 2004-10-28 | Sankaram Mantripragada | Oil-core compositions for the sustained release of hydrophobic drugs |
US20050129719A1 (en) * | 2003-12-15 | 2005-06-16 | Yu-Fang Hu | Concentrated emulsion formulation for silatecan |
US20050220835A1 (en) * | 2004-03-30 | 2005-10-06 | Jayaraman Ramesh B | Agent eluting bioimplantable devices and polymer systems for their preparation |
EP1909771A1 (en) * | 2005-08-02 | 2008-04-16 | Miv Therapeutics Inc. | Microdevices comprising nanocapsules for controlled delivery of drugs and method of manufacturing same |
JP5548364B2 (ja) * | 2006-10-03 | 2014-07-16 | 日本化薬株式会社 | レゾルシノール誘導体の高分子結合体 |
AR063111A1 (es) | 2007-10-03 | 2008-12-30 | Eriochem Sa | Una formulacion farmaceutica de taxano |
CN102038636B (zh) * | 2009-10-23 | 2014-08-13 | 天士力控股集团有限公司 | 一种含有螯合剂的紫杉烷类药物溶液及其制备方法 |
CN102038634B (zh) * | 2009-10-23 | 2014-12-10 | 天士力控股集团有限公司 | 一种含有助溶剂的紫杉烷类药物溶液及其制备方法 |
CN102038635A (zh) | 2009-10-23 | 2011-05-04 | 天津天士力集团有限公司 | 一种含有pH值调节剂的紫杉烷类药物溶液及其制备方法 |
TWI438009B (zh) * | 2010-02-19 | 2014-05-21 | Teikoku Pharma Usa Inc | 紫杉烷前-乳劑調配物及其製造與使用之方法 |
MX341082B (es) | 2010-05-03 | 2016-08-08 | Teikoku Pharma Usa Inc | Formulaciones de pro-emulsion de taxano no acuosas y metodos para hacer y usar las mismas. |
TWI472340B (zh) * | 2010-11-10 | 2015-02-11 | Tasly Holding Group Co Ltd | Taxanes containing solution and a preparation method of the co-solvent |
JO3685B1 (ar) | 2012-10-01 | 2020-08-27 | Teikoku Pharma Usa Inc | صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها |
CN109464382B (zh) * | 2019-01-08 | 2020-10-09 | 四川大学 | 一种可注射的高载药量的紫杉醇凝胶及其制备方法和应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2698543B1 (fr) * | 1992-12-02 | 1994-12-30 | Rhone Poulenc Rorer Sa | Nouvelles compositions à base de taxoides. |
US5430057A (en) * | 1993-09-30 | 1995-07-04 | Board Of Regents, The University Of Texas System | Parenteral busulfan for treatment of malignant disease |
US5597829A (en) * | 1994-05-09 | 1997-01-28 | Bionumerik Pharmaceuticals, Inc. | Lactone stable formulation of camptothecin and methods for uses thereof |
TW372967B (en) * | 1994-12-27 | 1999-11-01 | Kanebo Ltd | 1,4 benzoxazine derivative, pharmaceutical composition containing the same and use thereof |
-
1996
- 1996-06-28 US US08/672,594 patent/US5877205A/en not_active Expired - Fee Related
-
1997
- 1997-06-26 CA CA002259297A patent/CA2259297C/en not_active Expired - Fee Related
- 1997-06-26 CN CNB971969345A patent/CN1165300C/zh not_active Expired - Fee Related
- 1997-06-26 JP JP10504432A patent/JP2000515132A/ja not_active Ceased
- 1997-06-26 NZ NZ333737A patent/NZ333737A/en unknown
- 1997-06-26 WO PCT/US1997/011503 patent/WO1998000128A1/en not_active Application Discontinuation
- 1997-06-26 EP EP97933246A patent/EP0920311A4/en not_active Withdrawn
- 1997-06-26 AU AU36478/97A patent/AU722617B2/en not_active Ceased
-
1998
- 1998-12-28 NO NO986165A patent/NO986165L/no unknown
-
1999
- 1999-03-01 US US09/259,533 patent/US6107333A/en not_active Expired - Fee Related
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9434822B2 (en) | 2004-09-22 | 2016-09-06 | Nippon Kayaku Kabushiki Kaisha | Block copolymer, micelle preparation, and anticancer agent containing the same as active ingredient |
US8323669B2 (en) | 2006-03-28 | 2012-12-04 | Nippon Kayaku Kabushiki Kaisha | Polymer conjugate of taxane |
WO2007111211A1 (ja) * | 2006-03-28 | 2007-10-04 | Nippon Kayaku Kabushiki Kaisha | タキサン類の高分子結合体 |
US8940332B2 (en) | 2006-05-18 | 2015-01-27 | Nippon Kayaku Kabushiki Kaisha | High-molecular weight conjugate of podophyllotoxins |
US8334364B2 (en) | 2006-11-06 | 2012-12-18 | Nipon Kayaku Kabushiki Kaisha | High-molecular weight derivative of nucleic acid antimetabolite |
US8188222B2 (en) | 2006-11-08 | 2012-05-29 | Nippon Kayaku Kabushiki Kaisha | High molecular weight derivative of nucleic acid antimetabolite |
US8703878B2 (en) | 2007-09-28 | 2014-04-22 | Nippon Kayaku Kabushiki Kaisha | High-molecular weight conjugate of steroids |
USRE46190E1 (en) | 2007-09-28 | 2016-11-01 | Nippon Kayaku Kabushiki Kaisha | High-molecular weight conjugate of steroids |
US8920788B2 (en) | 2008-03-18 | 2014-12-30 | Nippon Kayaku Kabushiki Kaisha | High-molecular weight conjugate of physiologically active substances |
US9149540B2 (en) | 2008-05-08 | 2015-10-06 | Nippon Kayaku Kabushiki Kaisha | Polymer conjugate of folic acid or folic acid derivative |
US8808749B2 (en) | 2009-05-15 | 2014-08-19 | Nippon Kayaku Kabushiki Kaisha | Polymer conjugate of bioactive substance having hydroxy group |
US9018323B2 (en) | 2010-11-17 | 2015-04-28 | Nippon Kayaku Kabushiki Kaisha | Polymer derivative of cytidine metabolic antagonist |
US9346923B2 (en) | 2011-09-11 | 2016-05-24 | Nippon Kayaku Kabushiki Kaisha | Method for manufacturing block copolymer |
Also Published As
Publication number | Publication date |
---|---|
NO986165L (no) | 1999-02-25 |
EP0920311A4 (en) | 2001-10-04 |
NO986165D0 (no) | 1998-12-28 |
CA2259297C (en) | 2003-12-16 |
US6107333A (en) | 2000-08-22 |
AU3647897A (en) | 1998-01-21 |
US5877205A (en) | 1999-03-02 |
CN1165300C (zh) | 2004-09-08 |
CA2259297A1 (en) | 1998-01-08 |
NZ333737A (en) | 2000-02-28 |
EP0920311A1 (en) | 1999-06-09 |
AU722617B2 (en) | 2000-08-10 |
WO1998000128A1 (en) | 1998-01-08 |
CN1228022A (zh) | 1999-09-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2000515132A (ja) | 安定な非中毒性処方物中の非経口パクリタキセル | |
AU734695B2 (en) | Pharmaceutical compositions containing plasma protein | |
US5430057A (en) | Parenteral busulfan for treatment of malignant disease | |
EP2480207B1 (en) | Micelle encapsulation of therapeutic agents | |
KR101502533B1 (ko) | 우수한 안정성을 갖는 택산 유도체 함유 주사제용동결건조 조성물 및 이의 제조방법 | |
FI92556B (fi) | Menetelmä intravenoosisen farmaseuttisen koostumuksen valmistamiseksi | |
Sugahara et al. | Complete regression of xenografted human carcinomas by a paclitaxel–carboxymethyl dextran conjugate (AZ10992) | |
AU775158B2 (en) | Water-miscible pharmaceutical compositions of paclitaxel | |
CN103804472A (zh) | 一种紫杉烷类药物前体 | |
JP2003509372A (ja) | リン酸エストラムスチンおよびアミノ酸の非経口使用のための処方 | |
US20030082229A1 (en) | Parenteral chlorambucil for treatment of malignant and autoimmune disease and methods of use | |
CN110812335A (zh) | 装载疏水药物的丝素蛋白微纳米颗粒缓释制剂及制备方法 | |
KR20050060981A (ko) | 수용성 파클리탁셀 프로드럭 화합물 및 플라보노이드계화합물을 포함하는 경구용 항암 조성물 | |
CZ18181U1 (cs) | Farmaceutický prostředek s obsahem taxanového derivátu, určený pro přípravu infúzního roztoku |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040617 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20040617 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080212 |
|
A313 | Final decision of rejection without a dissenting response from the applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A313 Effective date: 20080701 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20080826 |